Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/41fcbb34-8121-4922-937b-a764d7fc747c/

LENSKART

LENSKART SOLUTIONS LTD
Chart
₹506.45
Latest Week 2026-06-05
HealthcareMedical Instruments & SuppliesMEGA
Snapshot 2026-06-07 · 0.0w · Fresh
0.12
OS Score
2.0%
Value
67.0%
Quality
50.0%
Momentum
4/9
F-Score
0.116
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
2.0%ile
P/E
177.4×
P/S
9.9×
P/B
10.0×
E/P
0.0056
FCF Yield
0.009
EBITDA/EV
0.021
SH Yield
-0.025
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
98.00000000
/100 — 1=cheapest
VC2 (Trending Value)
99.00000000
/100
VC3 (Buyback)
99.00000000
/100
P/E of 177.4x is premium-priced — the market is paying up for expected growth. VC2 score of 99.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
67.0%ile
ROE
0.056
ROA
0.034
Net Margin
0.056
Op Margin
0.080
GPA
0.422
Current
2.26
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.325
Earn Growth
0.668
Accruals
-0.082
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
50.0%ile
6M Return
21.4%
Vol 252d
42.2%
Vol 60d
43.1%
↑ Expanding
Max DD 12M
-14.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.12
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
6.2%
Sector Quality %ile
49.1%
P/E z-score
0.32
P/B z-score
0.94
Sector Avg OS
43.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SPARC Sun Pharma Advanced Research Company Limited 93.0% 72.0% 86.0% 83.0%
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
10.0% avg (7 factors)
Quality
C
50.4% avg (7 factors)
Momentum
B
64.2% avg (1 factors)
Risk
C
46.4% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.120—1—
Value %ile0.020—1—
Quality %ile0.670—0—
Momentum %ile0.500—0—
F-Score4.000—1—
Confidence0.848—1—
Volatility0.422—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
177.41
Earnings Yield (E/P)
0.0056
Price / Sales
9.94
Price / Book
10.02
Price / Cash Flow
52.45
FCF Yield
0.9%
EBITDA / EV
2.1%
Sales Yield (1/P·S)
0.0983
Shareholder Yield
Div + net buyback / mktcap
-2.5%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
5.6%
Return on Assets
3.4%
Net Margin
5.6%
Operating Margin
8.0%
Gross Profit / Assets
Novy-Marx GPA
42.2%
Current Ratio
2.26
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.082
External Financing
Net issuance — lower=better
0.151
MomentumPrice trend strength over different horizons
6M Return
21.4%
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
32.5%
Earnings Growth (YoY)
66.8%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
-2.5%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
98
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
99
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
99
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity